Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
40M
-
Shares change
-
+8.76M
-
Total reported value, excl. options
-
$918M
-
Value change
-
+$205M
-
Number of buys
-
60
-
Number of sells
-
-27
-
Price
-
$22.96
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2019
103 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q4 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40M shares
of 66.4M outstanding shares and own 60.22% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.42M shares), NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.31M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.29M shares), WELLINGTON MANAGEMENT GROUP LLP (3.32M shares), BAKER BROS. ADVISORS LP (2.71M shares), BlackRock Inc. (2.55M shares), FEDERATED HERMES, INC. (2.16M shares), PRIMECAP MANAGEMENT CO/CA/ (2.09M shares), and VANGUARD GROUP INC (1.68M shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.